- Home
- /
- Treatment
- /
- Page 122
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Histamine | For use as an adjunct to cytokine therapy in the treatment of malignant melanoma | EpiCept Corporation;777 Old Saw Mill River Road;Tarrytown, New York, 10591 | February 1, 2000 | |
Phenylbutyrate | Acute promyelocytic leukemia | Elan Drug Delivery, Inc.;1300 Gould Dr.;Gainesville, Georgia, 30504 | January 19, 2000 | |
Natural human lymphoblastoid interferon-alpha | Behçet’s Disease | Amarillo Biosciences, Inc.;4134 Business Park Drive;Amarillo, Texas, 79110 | January 18, 2000 | |
1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine hydrogen methanesulfonate | Hormone refractory prostate carcinoma | Cell Therapeutics, Inc.;201 Elliott Avenue West, Suite 400;Seattle, Washington, 98119 | January 18, 2000 | |
Levodopa and carbidopa | Late stage Parkinson's disease | AbbVie, Inc.;1 N. Waukegan Road, Building AP30-1;North Chicago, Illinois, 60064 | January 18, 2000 | |
Recombinant human keratinocyte growth factor | Reducing the incidence and severity of radiation-induced xerostomia | Swedish Orphan Biovitrum AB (publ) (SOBI);SE-112 76;Stockholm | December 20, 1999 | |
Adenovirus-based vector Factor VIII complementary DNA to somatic cells | Hemophilia A | GenStar Therapeutics Corporation;10835 Altman Row, Suite 150;San Diego, California, 92121 | December 15, 1999 | |
Histamine | Adjunct to cytokine therapy in the treatment of acute myeloid leukemia | EpiCept Corporation;777 Old Saw Mill River Road;Tarrytown, New York, 10591 | December 15, 1999 | |
Ubiquinone | Mitochondrial cytopathies | Gel-Tec, Division of Tishcon Corp.;30 New York Avenue, P. O. Box 331;Westbury, New York, 11590 | December 14, 1999 | |
Pentostatin | Peripheral T-cell lymphomas | SuperGen, Inc.;4140 Dublin Blvd., Suite 200;Dublin, California, 94568 | November 24, 1999 | |
Gemtuzumab ozogamicin | Acute myeloid leukemia | Wyeth Pharmaceuticals, Inc., a Pfizer Company;10646 Science Center Drive;San Diego, California, 92121 | November 24, 1999 | |
Alpha1-proteinase inhibitor (human) | For slowing the progression of emphysema in alpha1-antitrypsin deficient patients | CSL Behring L.L.C.;1020 First Ave., PO Box 61501;King of Prussia, Pennsylvania, 19406 | November 24, 1999 | |
Dimerizing drug that binds to mutated Fas protein/drug-binding domain fusion protein (FKBP) | Graft Versus Host Disease | Bellicum Pharmaceuticals, Inc.;6400 Fannin Street, Suite 2300;Houston, Texas, 77030 | November 24, 1999 | |
Gemtuzumab zogamicin | CD33-positive acute myeloid leukemia | Wyeth-Ayerst Laboratories;PO Box 8299;Philadelphia, PA, 19101-8299 | November 24, 1999 | |
Silver sulfadiazine and cerium nitrate | Patients with severe dermal burns | Alliance Pharmaceuticals Ltd;Avonbridge House, Bath Road, Chippenham;Wiltshire, SN15 2BB | November 17, 1999 | |
Somatropin (rDNA origin) | Long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | October 28, 1999 | |
Temoporfin | Palliative treatment of recurrent, refractory or second primary squamous cell carcinomas of the head and neck in patients considered to be incurable with surgery or radiotherapy | Biolitec Pharma Ireland Ltd.;United Drug House, Dublin; | October 28, 1999 | |
Teriparatide | Idiopathic osteoporosis | Biomeasure, Inc.;27 Maple St.;Milford, Massachusetts, 01757 | October 28, 1999 | |
Botulinum toxin type A | Dynamic muscle contractures in pediatric cerebral palsy patients | Ipsen Limited;1 Bath Rd., Maidenhead;Berkshire SL6 4UH | October 20, 1999 | |
L-glutamyl-L-tryptophan | AIDS-related Kaposi's sarcoma | Implicit Bioscience Pty Ltd;P. O. Box 2072., Toowong Business Center; | October 20, 1999 | |
Amifostine | Myelodysplastic syndromes | Clinigen Group plc;Pitcairn House, Crown Square, DE14 2WW; | October 4, 1999 | |
Peginterferon alfa-2a | Chronic myeloid leukemia | Hoffman-La Roche Inc.;340 Kingsland St.;Nutley, New Jersey, 07110 | September 30, 1999 | |
HLA-B7/Beta2M DNA Lipid (DMRIE/DOPE) Complex | Metastatic Melanoma | Vical Incorporated;9373 Towne Centre Dr., Suite 100;San Diego, California, 92121 | September 30, 1999 | |
Azathioprine | Oral manifestations of graft-versus-host disease | Oral Solutions, Inc.;787 Seventh Ave., 48th Floor;New York, New York, 10019 | September 14, 1999 | |
Epirubicin | Breast cancer | Pharmacia & Upjohn Company;0634-298-113, 7000 Portage Rd.;Kalamazoo, Michigan, 49001 | September 14, 1999 |